Table 2

Demographics of patients enrolled in DSD models

VariableEarly enrollers of DSD models (n=6340)Established enrollers of DSD models (n=25 857)
Age in years, median (IQR)36 (29–44)37 (29–44)
Age group, n (%)15–24727 (11)2589 (10)
25–342069 (33)8346 (32)
35–492658 (42)11 424 (44)
50+885 (14)3487 (13)
Sex, n (%)Female3914 (62)15 666 (61)
Male2426 (38)10 191 (39)
Location, n (%)Rural2501 (39)9078 (35)
Urban3839 (61)16 779 (65)
Year of ART initiation, n (%)20192897 (46)17 346 (67)
20203443 (54)8511 (33)
DSD type, n (%)Adherence groups149 (2)508 (2)
Community pick-up points671 (11)1461 (6)
Extended clinic hours85 (1)97 (<1)
Fast-track979 (15)6266 (24)
Home ART delivery355 (6)973 (4)
Multimonth dispensing4101 (65)16 552 (64)
ART months dispensed, n (%)<2636 (10)1476 (6)
32197 (35)5688 (22)
4–63507 (55)18 679 (72)
Outcome year, n (%)20202863 (45)17 283 (67)
20213477 (55)8574 (33)
Months on ART at outcome, median (IQR)17.9 (16.4–19.5)18.4 (16.7–19.8)
On DSD at outcome, n (%)Yes6340 (100)20 856 (81)
No0 (0)5001 (19)
Months on DSD at outcome, median (IQR)14.7 (13.0–16.5)5.8 (2.9–8.9)
Patient outcomes by 18 months after ART initiation, n (%)On treatment6133 (97)24 646 (95)
Died11 (<1)31 (<1)
Lost to follow-up192 (3)1169 (5)
Stopped ART4 (<1)10 (<1)
Stopped DSD0 (0)1 (<1)
  • ART, antiretroviral therapy; DSD, differentiated service delivery.